WaveMan
WaveMan · Company
LFST · Lifestance Health Group, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

LFST LifeStance Health (LFST) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-health services · CIK 0001845257
Quote by TradingView
Form 144 · 12
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
203
13F, latest reported quarter

What the filings say about LFST

Insiders, 180 days
-$666.6M net sold
8 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$185.8M
12 notices

LifeStance Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, LifeStance Health Group, Inc. insiders sold a net $666.6M of stock across 133 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
TPG GP A, LLC
SELL
2026-09-15 SECtraded 2026-09-11
18,409,705
$226.3M
+1.1%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 10, 2026.
  • The trade is 23.1% of the 79,691,702 shares held after it.
  • 2 other insiders sold within 30 days.
  • 203 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider TPG GP A, LLC sold about $226.3M of LFST on Sep 11, 2026; 2 other insiders sold within 30 days and 203 funds added in the latest 13F quarter.
Paunovich Vukasin
Chief Technology Officer
SELL
2026-09-04 SECtraded 2026-09-02
42,067
$541.4K
+1.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 10, 2026.
  • The trade is 20.5% of the 205,379 shares held after it.
  • 4 other insiders sold within 30 days.
  • 203 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Paunovich Vukasin sold about $541.4K of LFST on Sep 2, 2026; 4 other insiders sold within 30 days and 203 funds added in the latest 13F quarter.
DeLuca Teresa
Director
SELL
2026-08-18 SECtraded 2026-08-14
7,500
$95.1K
+0.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 13, 2026.
  • The trade is 7.7% of the 97,093 shares held after it.
  • 4 other insiders sold within 30 days.
  • 203 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director DeLuca Teresa sold about $95.1K of LFST on Aug 14, 2026; 4 other insiders sold within 30 days and 203 funds added in the latest 13F quarter.
DeLuca Teresa
Director
SELL
2026-08-14 SECtraded 2026-08-13
20,441
$250.0K
+3.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 19.5% of the 104,593 shares held after it.
  • 4 other insiders sold within 30 days.
  • 203 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director DeLuca Teresa sold about $250.0K of LFST on Aug 13, 2026; 4 other insiders sold within 30 days and 203 funds added in the latest 13F quarter.
Burdick Kenneth A
Director
SELL
2026-08-13 SECtraded 2026-08-11
500,000
$5.8M
+4.1%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (5 buys, 1 sale), the last on Aug 11, 2025.
  • +41.9% median (+41.9% mean) 90-day return after 2 previous buys.
  • The trade is 16.8% of the 2,970,810 shares held after it.
  • 4 other insiders sold within 30 days.
  • 203 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Burdick Kenneth A sold about $5.8M of LFST on Aug 11, 2026; 4 other insiders sold within 30 days and 203 funds added in the latest 13F quarter.
133 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 128 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$666.6M over 180 days
-$378.8M over 90 days · -$598.0M of it by a 10%+ holder
below 95% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
203 funds bought in last quarter
more than 78% of Healthcare Services
Revenue
+13.9% year over year
more than 56% of Healthcare Services
Margin
0.7% net margin
more than 52% of Healthcare Services
Buybacks
$97.6M repurchased, FY to 2026-06-30
more than 65% of Healthcare Services
Short interest
5.8% of the float short (float per yahoo 2026-10-26) · 2.5 days to cover · settled 2026-09-30
more than 55% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch LFST

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+153.0%12M
-6%+50%+106%+162%2025-102025-122026-022026-042026-062026-082026-10 2026-05-12 · TPG GP A, LLC sold $226.8M2026-09-11 · TPG GP A, LLC sold $226.3M2026-03-02 · TPG GP A, LLC sold $145.0M2026-08-10 · TPG GP A, LLC sold $144.9M2026-05-12 · BLACK DARREN M. sold $47.3M2026-03-02 · BLACK DARREN M. sold $30.2M2026-08-11 · Burdick Kenneth A sold $5.8M2026-06-26 · Bessler Robert sold $4.5M2026-06-26 · Bessler Robert sold $4.5M2026-05-12 · Bessler Robert sold $2.3M2026-05-12 · Shuey Eric sold $2.0M2026-09-02 · Paunovich Vukasin sold $541.4K2026-08-10 · Miller Lisa K sold $519.8K2026-08-10 · Paunovich Vukasin sold $481.7K2025-12-19 · Bessler Robert sold $422.2K2025-11-21 · Miller Lisa K sold $368.1K2025-12-17 · Varanakis Ann sold $345.0K2026-05-07 · Bessler Robert sold $320.6K2025-12-12 · Bessler Robert sold $279.1K2026-08-13 · DeLuca Teresa sold $250.0K2026-04-24 · Bessler Robert sold $219.1K2026-04-24 · Bessler Robert sold $219.1K2026-08-14 · DeLuca Teresa sold $95.1K2025-12-15 · Bessler Robert sold $43.3K2025-12-15 · Bessler Robert sold $43.3K2026-04-23 · Bessler Robert sold $27.1K2025-12-18 · Bessler Robert sold $22.5K2026-04-21 · Bessler Robert sold $17.9K2026-04-21 · Bessler Robert sold $17.9K2025-12-22 · Bessler Robert sold $6.0K2025-12-22 · Bessler Robert sold $6.0K2026-09-02 · Paunovich Vukasin filed to sell $541.2K2026-08-14 · DeLuca Teresa filed to sell $95.1K2026-08-13 · DeLuca Teresa filed to sell $250.0K2026-08-11 · Burdick Kenneth A filed to sell $5.8M2026-08-10 · Summit Partners Growth Equity Fund IX-A, L.P. filed to sell $18.5M2026-08-10 · Summit Partners Growth Equity Fund IX-B, L.P. filed to sell $11.6M2026-08-10 · Summit Investors GE IX-VC IV, LLC filed to sell $129.2K2026-08-10 · Summit Partners Entrepreneur Advisors Fund II, L.P. filed to sell $17.3K2026-08-10 · Summit Investors GE IX/VC IV (UK), L.P. filed to sell $13.5K2026-08-10 · Paunovich Vukasin filed to sell $481.7K2026-08-10 · Miller Lisa K filed to sell $519.8K2026-08-10 · TPG VIII Lynnwood Holdings Aggregation, L.P. filed to sell $147.9M2026-06-26 · Bessler Robert filed to sell $9.1M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns LFST: institutional holders (13F)

13F holdings, latest reported quarter
TPG GP A, LLC
111,744,614 sh
$1.2B
FMR LLC
58,252,466 sh
$623.9M
BlackRock, Inc.
36,348,507 sh
$389.3M
SUMMIT PARTNERS L P
23,310,115 sh
$249.7M
VANGUARD PORTFOLIO MANAGEMENT LLC
13,960,892 sh
$149.5M

Congress trades in LFST

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

LFST planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Paunovich Vukasin
Filed 2026-09-02
$541.2K
DeLuca Teresa
Filed 2026-08-14
$95.1K
DeLuca Teresa
Filed 2026-08-13
$250.0K
Burdick Kenneth A
Filed 2026-08-11
$5.8M
Summit Partners Growth Equity Fund IX-A, L.P.
Filed 2026-08-10
$18.5M

LFST mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Disruptive Medicine ETF
$1.8M position · as of 2026-05-31
4.3%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$3.1M position · as of 2026-06-30
2.2%
Putnam VT Small Cap Value Fund
$2.1M position · as of 2026-06-30
1.7%
Select Health Care Services Portfolio
$13.7M position · as of 2026-05-31
1.7%
PGIM Jennison Small Company Fund
$52.0M position · as of 2026-06-30
1.5%
Fidelity Healthy Future Fund
$209.6K position · as of 2026-07-31
1.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $666.6M sold by insiders over 180 days, 203 funds added last quarter, $185.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

LFST financials

Revenue growth
+13.9%
XBRL, annual
Net margin
0.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.6B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+3.2%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$173.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.19x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.80x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+3.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+3.8%
operating income after a 24.5% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+4.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$5.0B
market value at close 2026-10-23 on 2026-07-29 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+3.5%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.4B$1.3B$1.1B$859.5M
Operating income$24.1M-$31.6M-$189.1M-$210.2M
Net income$9.7M-$57.4M-$186.3M-$215.6M
Operating cash flow$146.2M$107.3M-$16.9M$52.8M
Cash$248.6M$154.6M$78.8M$108.6M
Long-term debt$265.9M$279.8M$280.3M$225.1M
SEC XBRL, fiscal years, as known on 2026-10-27

LFST Stock Sonar score 6/7 axes

Find similar shapesCompare

LFST ranks highest on institutional and government (78th percentile) and financial health (72nd), and lowest on insider conviction (2nd), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
45
Inputs
  • Return on equity+3.4% · 55 pct, sector of 70
  • Return on assets+2.3% · 63 pct, sector of 88
  • Return on invested capital+3.8% · 9 pct, universe of 1,069
  • Return on capital employed+4.1% · 52 pct, sector of 68
Financial health
72
Inputs
  • Debt to equity0.19x · 60 pct, sector of 61
  • Cash flow to debt0.80x · 83 pct, sector of 66
Growth
56
Inputs
  • Revenue growth, YoY+13.9% · 56 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
2
Inputs
  • Net Form 4 buying (codes P and S), 180d-$666.6M · 5 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
78
Inputs
  • Funds adding, latest quarter203 · 78 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
  • Short interest, % of float+5.8% · 45 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+5.5% · 83 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

LFST filings, in plain words

Are LifeStance Health insiders buying or selling LFST?

In the 180 days to 2026-10-27, LifeStance Health insiders were net sellers, a net $666.6M across purchases and sales reported on Form 4, by 8 sellers.

Are there planned insider sales of LFST?

Yes. 12 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $185.8M of stock; the latest, by Paunovich Vukasin, was filed 2026-09-02.

Read the full summary

In the 180 days to 2026-10-27, LifeStance Health insiders were net sellers of LFST, a net $666.6M across purchases and sales reported on Form 4 by 8 sellers. Most of that figure, $598.0M, came from a holder of 10% or more rather than an officer or director. None of the 15 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 12 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $185.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies